Angion Biomedica Corp. (ANGN)
NASDAQ: ANGN
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM
Angion Biomedica Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 653K | 1.65M | 25.94M | 1.46M | 540K | 371K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 433K | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 653K | 1.65M | 25.51M | 1.46M | 540K | 371K |
Operating Income | -10.74M | -21.83M | -10.34M | -10.92M | -10.77M | -7.78M | -4.61M | -7.05M | -9.05M | -9.04M | -14.48M | 16.74M | -15.76M | -18.24M | -19.94M |
Interest Income | 210K | 23K | 185K | 137K | 246K | 39K | 469K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.21M | -29.14M | -18.84M | -7.23M | -10.66M | -7.56M | -4.54M | -6.44M | -8.99M | -9.14M | -14.24M | 14.89M | -15.7M | -17.07M | -36.69M |
Net Income | -11.21M | -29.21M | -18.84M | -7.23M | -10.66M | -7.56M | -4.47M | -11.51M | -14.47M | -9.14M | -14.24M | 13.04M | -15.7M | -17.07M | -36.69M |
Selling & General & Admin | 2.96M | 709K | 3.14M | 2.74M | 3.51M | 2.83M | 4.28M | 3.75M | 3.31M | 3.62M | 4.47M | 4.21M | 3.93M | 4.34M | 6.01M |
Research & Development | 7.78M | 21.12M | 7.21M | 8.18M | 7.26M | 4.94M | 326K | 160K | 2.94M | 6.07M | 11.67M | 6.67M | 13.29M | 14.44M | 14.3M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 433K | n/a | n/a | n/a |
Operating Expenses | 10.74M | 21.83M | 10.34M | 10.92M | 10.77M | 7.78M | 4.61M | 3.9M | 6.25M | 9.69M | 16.13M | 11.31M | 17.22M | 18.78M | 20.31M |
Interest Expense | -176K | 330K | -137K | -49K | -1K | -714K | -70K | 402K | 259K | n/a | n/a | 1.85M | 110K | 124K | -2.17M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 21.83M | n/a | n/a | 10.77M | 7.78M | 4.61M | 3.9M | 6.25M | 9.69M | 16.13M | 11.74M | 17.22M | 18.78M | 20.31M |
Income Tax Expense | n/a | 70K | n/a | n/a | n/a | n/a | -70K | 5.07M | 5.48M | n/a | n/a | 1.85M | 54K | n/a | n/a |
Shares Outstanding (Basic) | 12.95M | 12.2M | 13.58M | 21.85M | 25.98M | 25.98M | 30.11M | 30.04M | 30.11M | 29.97M | 29.96M | 29.83M | 29.83M | 29.67M | 23.44M |
Shares Outstanding (Diluted) | 12.95M | 12.2M | 13.58M | 21.85M | 25.98M | 25.98M | 30.11M | 30.04M | 30.11M | 29.97M | 29.96M | 29.83M | 29.83M | 29.67M | 23.44M |
EPS (Basic) | -0.87 | -2.39 | -1.39 | -0.33 | -0.41 | -0.29 | -0.15 | -0.38 | -0.48 | -0.3 | -0.48 | 0.44 | -0.53 | -0.58 | -1.56 |
EPS (Diluted) | -0.87 | -2.39 | -1.39 | -0.33 | -0.41 | -0.29 | -0.15 | -0.38 | -0.48 | -0.3 | -0.48 | 0.44 | -0.53 | -0.58 | -1.56 |
EBITDA | -10.74M | -29.02M | -10.34M | -10.92M | -10.77M | -7.78M | -4.48M | -727K | -9.05M | -9.04M | -14.41M | 16.96M | -15.76M | -18.24M | -19.94M |
EBIT | n/a | 18.93M | n/a | n/a | -10.66M | -8.27M | -4.61M | -6.04M | -8.73M | n/a | n/a | 18.84M | -15.59M | -16.95M | -38.86M |
Depreciation & Amortization | n/a | -207.5K | n/a | n/a | -39.59K | 122.08K | 125K | 6.32M | 6.09M | 232K | 228K | 223K | 217K | 206K | 155K |